Drawing for NEW LIFE AGENCY INC. THE SURROGACY INSURANCE EXPERTS

USPTO serial 87372097

NEW LIFE AGENCY INC. THE SURROGACY INSURANCE EXPERTS

Reviewed by CopyMark Law Group

Reg. 5322770Status 710
Filing date
Status date
Registration date
Oct 31, 2017
Examiner
REID, CAILE MAUREEN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with NEW LIFE AGENCY INC. THE SURROGACY INSURANCE EXPERTS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marc E. Hankin

Marc E. Hankin Hankin Patent Law, APC11414 Thurston CircleLos Angeles, CA 90049United States

Goods and services

ClassDescriptionStatusFirst use
036Insurance actuarial services; Insurance administration in the field of health for use in connection with assisted reproduction medical techniques, assisted reproduction drug therapy, artificial insemination, in vitro fertilization, fertility enhancement therapy, fertility enhancement drug therapy, third party egg donation, third party sperm donation, and third party surrogacy, surrogate maternity and delivery medical care, IVF maternity and delivery medical care, and newborn medical care; Insurance agencies in the field of health for use in connection with assisted reproduction medical technologies, assisted reproduction drug therapy, artificial insemination, in vitro fertilization, fertility enhancement therapy, third party egg donation, third party sperm donation, surrogate maternity and delivery medical care, IVF maternity and delivery medical care, and newborn medical care; Insurance agency and brokerage; Insurance brokerage services; Insurance brokerage in the field of health for use in connection with assisted reproduction medical techniques, assisted reproduction drug therapy, artificial insemination, in vitro fertilization, fertility enhancement therapy, fertility enhancement drug therapy, third party egg donation, third party sperm donation, and third party surrogacy, surrogate maternity and delivery medical care, IVF maternity and delivery medical care, and newborn medical care; Insurance claims administration; Insurance claims processing; Insurance underwriting in the field of health for use in connection with assisted reproduction medical techniques, assisted reproduction drug therapy, artificial insemination, in vitro fertilization, fertility enhancement therapy, fertility enhancement drug therapy, third party egg donation, third party sperm donation, and third party surrogacy, surrogate maternity and delivery medical care, IVF maternity and delivery medical care, and newborn medical careSECTION 8 - CANCELLEDMar 9, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 10, 2024C8..CANCELLED SEC. 8 (6-YR)—
Dec 4, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 4, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 4, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 4, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 4, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 18, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 18, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 18, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 18, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 18, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 31, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 31, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 15, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 15, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 26, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 12, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 9, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Jun 9, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 9, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 9, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 8, 2017DOCKASSIGNED TO EXAMINER—
Mar 21, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 18, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance